Welcome to our dedicated page for Moolec Science news (Ticker: MLEC), a resource for investors and traders seeking the latest updates and insights on Moolec Science stock.
Moolec Science SA (NASDAQ: MLEC) generates news at the intersection of food-tech, life sciences, and agricultural biotechnology. The company regularly issues updates on how it engineers plants and microbes to produce animal proteins, nutritional oils, bioactive compounds, and biological inputs for regenerative agriculture through its Molecular Farming and precision fermentation platforms.
News about Moolec often covers progress in its key ingredient programs, such as its GLASO safflower technology enriched in gamma-linolenic acid and its Piggy Sooy™ soybean platform engineered to express porcine hemeproteins. Press releases have highlighted regulatory approvals, including feed and food approval for GLASO technology in Argentina and U.S. regulatory milestones for Piggy Sooy™, as well as large-scale agricultural campaigns and acreage expansion in the United States.
Investors and industry observers can also find coverage of Moolec’s corporate and strategic developments. Recent announcements include the closing of a strategic business combination with Bioceres Group Limited, Gentle Technologies Corp, and Nutrecon LLC, which expanded Moolec’s activities into ag-biologicals, biomaterials, and R&D services. The company also reports on the integration of Mycofood™, its fungal-based alternative protein platform produced via precision fermentation.
Moolec’s news flow additionally includes capital markets and compliance updates, such as Nasdaq determination letters related to minimum bid price, stockholders’ equity, and filing timelines, as well as share consolidations and reverse stock splits intended to support continued listing on the Nasdaq Capital Market. For readers tracking MLEC, this news page provides a centralized view of operational milestones, regulatory events, strategic transactions, and listing-related actions that shape the company’s trajectory in the food-tech and life sciences sectors.
Moolec Science SA (NASDAQ:MLEC) announced that the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) concluded that its GLA safflower plants pose no greater pest risk than non-GE safflower plants. This regulatory clearance enhances Moolec's operational efficiency, as permits for interstate movement and growing these plants are no longer required. CEO Gastón Paladini highlighted this milestone as a validation of their regulatory strategy, while Chief of Technology Martin Salinas expressed optimism about upcoming regulatory reviews. Moolec aims to improve food products' nutritional profiles and sustainability through its Molecular Farming technology.
Moolec Science SA (NASDAQ: MLEC) announced it will ring the Nasdaq closing bell on January 17, 2023, celebrating its trading debut on January 3, 2023. This milestone reflects the company's pioneering role in the Molecular Farming movement, aimed at producing animal proteins in plants for enhanced food security and sustainability. CEO Gastón Paladini emphasized that the listing increases visibility and access to global capital markets, fostering growth and innovation in alternative proteins. Moolec Science develops technology with over a decade of research, boasting a diversified patent portfolio for its innovations in food.
Moolec Science Ltd. and LightJump Acquisition Corporation have successfully completed their business combination on December 30, 2022. Moolec Science will now trade on Nasdaq under the tickers MLEC for its common shares and MLECW for its warrants, starting January 3, 2023. Moolec Science specializes in producing animal proteins in plants through Molecular Farming, positioning itself as a leader in the alternative protein sector. The company aims to innovate food systems while enhancing taste, nutrition, and sustainability.